ISSN 2639-9431
Vol. 8, Issue 4, 2025December 06, 2025 EDT
A Validated Serum Biomarker Signature for the Non-Invasive Diagnosis of Endometriosis
A Validated Serum Biomarker Signature for the Non-Invasive Diagnosis of Endometriosis
Articles in Vol. 8, Issue 4, 2025
Vol. 8, Issue 4, 2025
- Development and Characterization of Bromocriptine Mesylate Loaded Nanostructured Lipid Carriers for Enhanced Nose-to-Brain DeliveryDarshan KAAnita R DesaiMallappa ShalavadiBasavaraj S. NainegaliLaxman S Vijapur
- GIMAP and Lipid Metabolism Imaging in Clear Cell Renal Cell Carcinoma: A Negative Radiogenomic AnalysisFederico GrecoMarco CataldoAndrea PanunzioAlessandro TafuriBruno Beomonte ZobelCarlo Augusto Mallio
- A Validated Serum Biomarker Signature for the Non-Invasive Diagnosis of EndometriosisRusul F. AbediAhmed Jasim MohammedAbbas ChyadRedha Dawud Abd AlredhaGhanim A. AbbasKrarr Haider Haddawi
- Comparing CRISPR-Cas9 Gene Therapy Delivery Systems: Implications and Optimization for HyperargininemiaJad MadaniHumza N. ZubairGhazi A. SaroyaRachel E.N. ReyesRami Madani
- From BioMAG® to Feraheme®: Overview of the Intellectual Property HistoryErnest GromanDmitri Simberg
Abedi, Rusul F., Ahmed Jasim Mohammed, Abbas Chyad, Redha Dawud Abd Alredha, Ghanim A. Abbas, and Krarr Haider Haddawi. 2025. “A Validated Serum Biomarker Signature for the Non-Invasive Diagnosis of Endometriosis.” Precision Nanomedicine 8 (4): 1645–58. https://doi.org/10.33218/001c.153841.